What is Veracyte Inc Quarterly Revenue?

Veracyte Inc Quarterly Revenue Veracyte Inc Jun-2026 Quarterly Revenue is $150 Million which is growth of 15.5% YoY.

What is Veracyte Inc Quarterly Net Profit?

Veracyte Inc Quarterly Net Profit Veracyte Inc Jun-2026 Quarterly Net Profit is $25 Million which is growth of 2701.0% YoY.

What is Veracyte Inc Annual Revenue?

Veracyte Inc Annual Revenue Veracyte Inc Dec-2025 Annual Revenue is $517 Million which is growth of 16.0% YoY.

What is Veracyte Inc Annual Net Profit?

Veracyte Inc Annual Net Profit Veracyte Inc Dec-2025 Annual Net Profit is $66 Million which is growth of 174.9% YoY.

What is Veracyte Inc Total Shareholders Fund?

Veracyte Inc Total Shareholders Fund Veracyte Inc Dec-2025 Total Shareholders Fund is $1,310 Million which is growth of 11.4% YoY.

What is Veracyte Inc Total Assets?

Veracyte Inc Total Assets Veracyte Inc Dec-2025 Total Assets is $1,406 Million which is growth of 8.2% YoY.

What is Veracyte Inc Book Value Per Share?

Veracyte Inc Book Value Per Share Veracyte Inc Book Value Per Share is $16 which is growth of 9.2% YoY.

What is Veracyte Inc ROE?

Veracyte Inc ROE Veracyte Inc ROE is 0% which is growth of 0% YoY.

What is Veracyte Inc Cash From Operating Activity?

Veracyte Inc Cash From Operating Activity Veracyte Inc Dec-2025 Cash From Operating Activity is $136 Million which is growth of 81.5% YoY.

What is Veracyte Inc Net Cash Flow?

Veracyte Inc Net Cash Flow Veracyte Inc Dec-2025 Net Cash Flow is $123 Million which is growth of 417.9% YoY.

Veracyte Inc

XNAS: VCYT

Mid-range Performer

Download real time

0.40(0.93%)

28.57% Fall from 52W High

935.3K

XNAS Volume

XNAS 14 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Veracyte Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Veracyte Inc share price target, revenues, EPS, net income and more

Veracyte Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Veracyte Inc Jun-2026 Quarterly Revenue is $150 Million which is growth of 15.5% YoY.
POSITIVE
Quarterly Net Profit Veracyte Inc Jun-2026 Quarterly Net Profit is $25 Million which is growth of 2701.0% YoY.

Veracyte Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	150.3	139.1	140.6	131.9	130.2	114.5	118.6	115.9	114.4	96.8	98.2	90.1	90.3
CostOfRevenue_Q Cost Of Rev.	41.8	37.9	38.7	40.6	40.4	35	39.9	36.9	36.5	31.5	29.4	27.6	29.7
GrossProfit_Q Gross Profit	108.6	101.2	102	91.3	89.8	79.5	78.8	79	77.9	65.4	68.8	62.5	60.6
OEXPNS_Q Operating Exp. ⌄	85.6	78.5	62.1	68.2	75.5	78.3	72.7	66.3	73	69	71.8	58.8	70.2
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	55.7	50.8	43.5	50.7	57.6	59.2	54.8	47.3	55	49	48.2	39.5	50.1
ResearchAndDevlopmentExpenses_Q RnD Exp.	29.4	27.1	20.9	16	16.3	17.7	19.3	17.6	16.5	16	18.7	13.3	12.5
OP_Q Operating Profit	23	22.7	39.9	23.1	14.3	1.2	6	12.7	5	-3.7	-3	3.7	-9.5
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	3.9	3.5	3.5	3.5	2.9	2.8	2.9	2.9	2.7	2.7	2.8	2.1	1.3
Others_Q Other Interest Earned	3.9	3.5	3.5	3.5	2.9	2.8	2.9	2.9	2.7	2.7	2.8	2.1	1.3
IntExpNonOperating_Q Interest Exp. Non Operating						-
PBT_Q Profit Before Tax	26.5	30	40.6	18.9	1.3	7.4	3.4	16.9	7.4	-1.9	-30.5	-29.8	-8.3
TAX_Q Tax	1	1.3	-0.5	-0.3	2.2	0.4	-1.7	1.7	1.6	-0	-2.2	-0.2	0.1
NICommonStockholders_Q Net Income Common Stockholders ⌄	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
NP_Q Net Profit	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
EPS_Q Basic EPS	0.3	0.4	0.5	0.2	-0	0.1	0.1	0.2	0.1	-0	-0.4	-0.4	-0.1
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.5	0.5	0.5	0.5	0.4	0.3	0.4	0.3	0.3	-0	0.2	0.1	-0.1
SHARE_Q Number Of Shares End	80	79.5	79.2	78.7	78.4	78	77.6	77	76.5	74.8	73.1	72.8	72.5
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
NormalizedIncome_Q Normalized Income	44.3	42.1	42.8	41	35	24.5	29	26	23.4	7	15.3	13.2	-0.1
InterestIncome_Q Interest Income	3.9	3.5	3.5	3.5	2.9	2.8	2.9	2.9	2.7	2.7	2.8	2.1	1.3
INT_Q Interest						-
NetInterestIncome_Q Net Interest Income	3.9	3.5	3.5	3.5	2.9	2.8	2.9	2.9	2.7	2.7	2.8	2.1	1.3
EBIT_Q EBIT	22.6	26.5	37.1	15.4	-1.7	4.7	0.6	14	4.7	-4.6	-33.3	-31.8	-9.5
EBITDA_Q EBITDA	27.5	31.9	42.4	20.7	3.8	10	6.8	19.8	10.4	1	-27	-24.5	-2.7
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	37.4	33.1	31.1	36.8	36.5	31.3	31.4	33	32.7	30.5	28.5	26.8	28.9
ReconciledDepreciation_Q Reconciled Depr.	4.8	5.4	5.3	5.3	5.5	5.4	6.3	5.9	5.7	5.6	6.3	7.3	6.9
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	25.5	28.7	41.2	19.1	-1	7.1	5.1	15.2	5.7	-1.9	-28.3	-29.6	-8.4
NormalizedEBITDA_Q Normalized EBITDA	31.7	35.4	48.7	31.9	23	3	15.3	21.4	13.3	4.7	6.5	13.2	-1.3

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Veracyte Inc competitor comparison and performance snapshot within industry

Veracyte Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Veracyte Inc Dec-2025 Annual Revenue is $517 Million which is growth of 16.0% YoY.
POSITIVE
Annual Net Profit Veracyte Inc Dec-2025 Annual Net Profit is $66 Million which is growth of 174.9% YoY.

Veracyte Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	20.4%	34.5%		517.1	445.8	361.1	296.5	219.5	117.5	120.4	92	72	65.1	49.5
TotalOperatingRevenues_A Operating Rev. Ann.	20.4%	34.5%	561.9	517.1	445.8	361.1	296.5	219.5	117.5	120.4	92	72	65.1	49.5
CostOfRevenue_A Cost Of Rev. Ann.	15%	30.1%	158.9	154.6	147.6	112.9	101.6	74.4	41.5	36.5	33.1	28.2	25.5	21.5
GrossProfit_A Gross Profit Ann.	23%	36.7%	403	362.5	298.1	248.2	195	145.1	76	83.8	58.9	43.8	39.6	28
OEXPNS_A Operating Exp. Ann.	6.8%	20.6%	294.3	284.3	278.1	265	233.6	225.5	111.4	99	81.2	70.3	68.4	61.5
OP_A Operating Profit Ann.	-	-	108.6	78.3	20	-16.9	-38.7	-80.4	-35.4	-15.1	-22.2	-26.5	-28.8	-33.5
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	91.8%	-	14.4	12.7	11.2	7.3	1.8	-0.1	-0.2	-0.7	-2	-4.9	-2.8	-0.4
Others_A Other Interest Earned Ann.	85.2%	-	14.4	12.7	11.2	7.3	2	0.1	-	-	-	-	-	-
IntExpNonOperating_A Interest Exp. Non Operating Ann.	-	-				0	0.2	0.2	0.2	0.7	2	3.4	2.8	0.4
OtherExpenses_A Other Exp. Ann.	-	-		-22.8	-5.4	-67.1	0.5	-1.2	0.7	3.2	1.2	0.5	0.2	0.1
PBT_A PBT Ann.	-	-	116	68.2	25.7	-76.6	-36.4	-81.7	-34.9	-12.6	-23	-31	-31.4	-33.7
TAX_A Tax Ann.	166.8%	-	1.5	1.9	1.6	-2.2	0.1	-6.1	-	-	-	-	-	-
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
NP_A Net Profit Ann.	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
EPS_A EPS Ann.	-	-		0.8	0.3	-1	-0.5	-1.1	-0.7	-0.3	-0.6	-0.9	-1.1	-1.3
DilutedEPS_A Diluted EPS Ann.	-	-		0.8	0.3	-1	-0.5	-1.1	-0.7	-0.3	-0.6	-0.9	-1.1	-1.3
SHARE_Q Number Of Shares End	3.3%	6.4%		79.2	77.6	73.1	71.8	71.1	58.1	49.1	40.8	34.1	31.7	27.7
TotalExpenses_A Total Exp. Ann.	9.4%	23.5%		438.9	425.8	377.9	335.2	299.9	152.9	135.5	114.2	98.5	93.9	83
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
NormalizedIncome_A Normalized Income Ann.	-	-	170.2	143.2	93	23.4	-12.2	-53.6	-19.9	-2.8	-17	-24.4	-24.9	-28
InterestIncome_A Interest Income Ann.	85.2%	-	14.4	12.7	11.2	7.3	2	0.1	-	-	-	-	-	-
INT_A Interest Ann.	-	-				0	0.2	0.2	0.2	0.7	2	3.4	2.8	0.4
EBITDA_A EBITDA Ann.	-	-	122.5	77	38.1	-56.7	-12.3	-62	-26.7	-7.8	-17.1	-23.8	-25.1	-31.1
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	11%	27.6%	138.3	135.7	127.5	109.8	99.3	72.6	40.1	35.2	31.9	27.5	23	20
ReconciledDepreciation_A Reconciled Depr. Ann.	-6.2%	22.1%	20.8	21.4	23.5	27.2	25.9	19.6	7.9	4.1	3.9	3.8	3.5	2.3
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-	114.5	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
NormalizedEBITDA_A Normalized EBITDA Ann.	-	-	147.7	112.9	54.6	18.2	-10.5	-60.7	-26.7	-7.8	-17.1	-23.8	-25.1	-31.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

16%

2Y CAGR

19.7%

3Y CAGR

20.4%

5Y CAGR

34.5%

7Y CAGR

28%

10Y CAGR

26.4%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

175.5%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

2.2%

2Y CAGR

3.6%

3Y CAGR

6.8%

5Y CAGR

20.6%

7Y CAGR

19.6%

10Y CAGR

16.5%

Operating Expenses Annual Cr growth is lower than historical averages.

Veracyte Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Veracyte Inc Dec-2025 Total Shareholders Fund is $1,310 Million which is growth of 11.4% YoY.
POSITIVE
Total Assets Veracyte Inc Dec-2025 Total Assets is $1,406 Million which is growth of 8.2% YoY.

Veracyte Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	6.7%	25.2%	1,406	1,300	1,114.9	1,156.4	1,187.8	457.2	275.2	120.6	78.7	101	75.3
CA_A Total Current Assets Ann.	25.2%	5.4%	488.4	372.3	285.6	248.6	243.1	375.7	187.7	97	53.9	73.6	47.9
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	32.2%	3.4%	412.9	289.4	216.5	178.9	173.2	349.4	159.3	78	33.9	59.2	39.1
Receivables_A Change In Account Receivables Ann.	0.5%	19.3%	44.7	46.5	40.4	44	41.5	18.5	19.3	13.2	12.7	8.8	3.5
Inventories_A Inventories Ann.	12.9%	34.4%	20.6	21.8	16.1	14.3	11.2	4.7	6.8	3.4	5.3	3.5	3.8
OtherCurrentAssets_A Other Current Assets Ann.	-3.6%	26.3%	10.3	14.6	12.7	11.5	17.2	3.2	2.2	2.4	2	2.1	1.5
TotalNonCurrentAssets_A Total Non Current Assets Ann.	0.4%	62.3%	917.6	927.8	829.3	907.8	944.7	81.5	87.5	23.7	24.7	27.4	27.4
NetPPE_A Net PPE Ann.	23.9%	28.5%	58.8	71.1	30.9	30.9	31.1	16.8	17.7	8.9	9.7	11.5	10.3
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-25.1%	5.4%	2.6	8.5	6.9	6.2	3	2	2	1.7	0.9	0.7	0.8
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	5.9%	21.8%	96.4	124.1	70.8	81.2	91.3	35.9	35.8	40.9	41.4	41.5	24
CL_A Total Current Liabilities Ann.	-1.5%	29%	59.9	78.6	61.2	62.6	64.2	16.8	17.5	13.1	12	11.5	14.7
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	10.7%	35.8%	25.9	21.9	24.9	19.1	21	5.6	6	5.3	6.7	5.4	9.6
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	0%	20.7%	4.1	7.5	5.1	4.1	4.8	1.6	1.4	1.4	-	-	-
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-22.7%	24.6%	1.2	1.7	2	2.6	4.7	0.4	-	-	-		1
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-40.9%	-	1.3	17	2.8	6.3	2.9	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	25.2%	13.7%	36.5	45.4	9.6	18.6	27.2	19.2	18.3	27.8	29.4	29.9	9.3
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	49.3%	27.2%	35.6	43.2	7.5	10.7	14.1	10.7	12.2	23.9	25.3	25.5	5
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	6.8%	25.5%	1,309.6	1,176	1,044.1	1,075.2	1,096.5	421.2	239.5	79.8	37.2	59.6	51.3
EQCAP_A Equity Share Capital Ann.	6.8%	25.5%	1,309.6	1,176	1,044.1	1,075.2	1,096.5	421.2	239.5	79.8	37.2	59.6	51.3
CapitalStock_A Capital Stock Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0
RetainedEarnings_A Retained Earnings Ann.	-	-	-377.6	-444	-468.1	-393.7	-357.2	-281.6	-246.7	-234.1	-211.1	-180.1	-148.7
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-8.2	-36.1	-24	-31.4	-15.1	-	-	-	-	-	-
TotalCapitalization_A Total Capitalization Ann.	6.8%	25.4%	1,309.6	1,176	1,044.1	1,075.2	1,096.5	422	240.2	103.7	62.2	84.5	56.3
TangibleAssets_A Tangible Assets Ann.	30.4%	4.8%	453.3	327.9	252.5	204.4	185.9	358.6	171.7	66.7	23.1	44.4	35
WC_A Working Capital Ann.	32.1%	3.6%	428.4	293.6	224.4	186	179	358.9	170.2	83.9	41.9	62.1	33.2
InvestedCapital_A Invested Capital Ann.	6.8%	25.4%	1,309.6	1,176	1,044.1	1,075.2	1,097.6	422	240.2	105	62.2	84.5	56.3
TangibleBookValue_A Tangible Book Value Ann.	30.4%	4.8%	453.3	327.9	252.5	204.4	185.9	358.6	171.7	66.7	23.1	44.4	35
Borrowings_A Borrowings Ann.	39.3%	26.4%	39.7	50.7	12.6	14.7	18.9	12.3	13.6	25.3	25.3	25.5	5
NetDebt_A Net Debt Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ShareIssued_A Share Issued Ann.	3.3%	6.4%	79.4	77.8	73.3	72	71.1	58.2	49.6	40.9	34.2	33.8	27.7
SHARE_Q Number Of Shares End	3.3%	6.4%	79.2	77.6	73.1	71.8	71.1	58.1	49.1	40.8	34.1	31.7	27.7

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

8.2%

2Y CAGR

12.3%

3Y CAGR

6.7%

5Y CAGR

25.2%

7Y CAGR

42%

10Y CAGR

34%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

-23.8%

2Y CAGR

-1.1%

3Y CAGR

-1.5%

5Y CAGR

29%

7Y CAGR

24.3%

10Y CAGR

15.1%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

11.4%

2Y CAGR

12%

3Y CAGR

6.8%

5Y CAGR

25.5%

7Y CAGR

49.1%

10Y CAGR

38.3%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Veracyte Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Veracyte Inc Book Value Per Share is $16 which is growth of 9.2% YoY.
NEUTRAL
ROE Veracyte Inc ROE is 0% which is growth of 0% YoY.

Veracyte Inc, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	2.00%	-6.55%	-3.12%	-9.19%	-9.53%	-6.37%	-23.08%	-34.50%	-35.57%	-48.11%
ROE_A ROE Ann. %	-	-	-	2.17%	-7.02%	-3.37%	-9.96%	-10.57%	-7.89%	-39.32%	-64.05%	-56.59%	-72.77%
ROIC_Q ROIC %	-	-	-	0.2	-2.9	-0.4	-0.9	-1.8	-3	-2.4	-11.4	-5.1	-13.3
OPMPCT_A OPM Ann. %	-	-	15.14%	4.49%	-4.67%	-13.04%	-36.61%	-30.12%	-12.57%	-24.16%	-36.88%	-44.25%	-67.60%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	7.8	7.4	8	9.4	7.2	7.2	7.6	6.4	7	5.8
ASETTO_A Asset Turnover Ann. %	-	-	-	0.4	0.3	0.3	0.3	0.3	0.6	0.9	0.8	0.7	0.7
WCTO_A Working Capital Turnover Ann.	-9.1%	32%	1.2	1.5	1.6	1.6	1.2	0.3	0.7	1.1	1.7	1.1	1.5
QuickRatio_A Quick Ratio Ann.	-	-	-	4.3	4.2	3.6	3.4	21.9	10.2	7	3.9	5.9	2.9
CRATIO_A Current Ratio Ann.	-	-	-	4.7	4.7	4	3.8	22.4	10.7	7.4	4.5	6.4	3.3
IC_A Interest Coverage Ratio Ann.	-	-	-	12,873	-5,106.5	-183	-337.8	-151.4	-17.6	-10.7	-8.1	-10.4	-88.2
LTDE_A LT Debt To Equity Ann.	-	-	-	0	0	0	0	0	0.1	0.3	0.7	0.4	0.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Veracyte Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Veracyte Inc Dec-2025 Cash From Operating Activity is $136 Million which is growth of 81.5% YoY.
POSITIVE
Net Cash Flow Veracyte Inc Dec-2025 Net Cash Flow is $123 Million which is growth of 417.9% YoY.

Veracyte Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	162.9%	-	136.3	75.1	44.2	7.5	-31.6	-9.7	-3.2	-13.5	-23.9	-28	-27
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-	66.4	24.1	-74.4	-36.6	-75.6	-34.9	-12.6	-23	-31	-31.4	-33.7
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-6.2%	22.1%	21.4	23.5	27.2	25.9	19.6	7.9	4.1	3.9	3.8	3.5	2.3
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-6.2%	22.1%	21.4	23.5	27.2	25.9	19.6	7.9	4.1	3.9	3.8	3.5	2.3
DeferredTax_A Deferred Tax Ann.	-	-	-0.6	-0.2	-3.8	0.1	-6.3	-	-	-	-	-	-
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-0.6	-0.2	-3.8	0.1	-6.3	-	-	-	-	-	-
EmployeesStockOptions_A ESOPs Ann.	17.8%	27.4%	43.6	36.3	33.1	26.7	22.5	13	9.8	6	6.6	6.4	5.6
OtherNonCashItems_A Other Non Cash Items Ann.	-	-	-12.3	7.1	-1.2	3.6	2.7	2.7	0.3	0.3	2.1	-0.2	-1.8
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-2.3	-21.3	-4.2	-16.4	4.2	-0.5	-4.9	-0.7	-5.4	-6.4	0.6
ChangeInReceivables_A Change In Receivables Ann.	-	-	-0.7	-6.4	3.9	-4.5	-8.6	1	-6.2	-0.5	-4	-5.3	-0.6
ChangeInInventory_A Change In Inventory Ann.	-	-	-2.9	-5.9	-1.7	-3	-1.5	1.1	-3.4	1.9	-1.9	0.3	-0.1
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-	-	5.3	-0.8	-0.8	-3.8	19.6	-0.2	5.1	-0.8	0.6	-1	0.9
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	0.5	-1.6	-0.8	-3.1	-0.2	0	-0.4	-0.8	-0.2	0	-0
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-2.5	-5.4	-4.3	-3.5	-1.8	-1.4	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-	-	-	-	-	-	-0.2	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-9.2	-56.3	15.1	-29.4	-739.2	-3.8	-42.7	-1.9	-1.2	-4.2	-6.7
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-9.7	-11.3	-10	-8.6	-5.4	-2.8	-2.7	-1.9	-1.3	-4.2	-6.2
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-9.7	-11.3	-10	-8.6	-5.4	-2.8	-2.8	-1.9	-1.8	-4.2	-6.2
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-2.9	5			-736.8		-40	-	-		-
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-2.9	-			-736.8		-40	-	-		-
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-150	-50	-19.7	-33.5		-1	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	129.4%	-	153.3		44.8	12.7	3	-	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	-	-	0.1		-0.5
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-4.2	4.9	2.8	3.5	596.3	203.6	127.3	59.5	-0.2	52.3	37.7
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-			-1.3		-0.1	-25.2	-0.3	-2.3	19.2	-
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-			-1.3		-0.1	-25.2	-0.3	-2.3	19.2	-
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-	-			593.8	193.8	137.9	55	0.2	32	37.3
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-			593.8	193.8	137.9	55	0.2	32	37.3
CommonStockPayments_A Common Stock Payments Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
dividend_1Y_actual Dividend 1year	-	-
DividendPerShare_A Dividend Per Share Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-18.3	-15.1	-6.7	-3.2	-9	-3.9	-	0.4	-	-	-0.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	32.9%	0.8%	364.2	240.6	217.3	155	174	350	159.9	78.6	33.9	59.2	39.1
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-8.4%	122.9	23.7	62.2	-18.4	-174.5	190.1	81.3	44.1	-25.3	20.1	4.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	11.4%	8.5%	240.6	217.3	155	174	350	159.9	78.6	34.5	59.2	39.1	35
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	-	-	-	2.2	1.7	0.6	0.1	0.1	0	0.1	0	0	0
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-	-	-			0	0	0	0.3	1.6	2.7	2.2	0.3
CapitalExpenditure_A Capex Ann.	-	-	-9.7	-11.3	-10	-8.6	-5.4	-2.8	-2.8	-1.9	-1.8	-4.2	-6.2
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-			593.8	193.8	137.9	55	0.2	32	37.3
IssuanceOfDebt_A Issuance Of Debt Ann.	-	-	-	-	-	-	-	-			24.9	24.5	-
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-			-1.3		-0.1	-25.2	-0.3	-27.2	-5.3	-
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
FreeCashFlow_A Free Cash Flow Ann.	-	-	126.6	63.8	34.3	-1	-37	-12.6	-6	-15.4	-25.7	-32.2	-33.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

81.5%

2Y CAGR

75.6%

3Y CAGR

162.9%

Cash from Operating Activity Annual growth is lower than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

28.57% Fall from 52W High

Veracyte Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Veracyte Inc - Forecaster

Forecaster Analyst Estimates for Veracyte Inc share price target, revenues, EPS, net income and more

Veracyte Inc - Earnings Report - Quarterly Results

Veracyte Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Veracyte Inc Jun-2026 Quarterly Revenue is $150 Million which is growth of 15.5% YoY.

Quarterly Net Profit Veracyte Inc Jun-2026 Quarterly Net Profit is $25 Million which is growth of 2701.0% YoY.

Veracyte Inc - Competitors/Peers

Veracyte Inc competitor comparison and performance snapshot within industry

Veracyte Inc - Earnings Report - Annual Results

Veracyte Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Veracyte Inc Dec-2025 Annual Revenue is $517 Million which is growth of 16.0% YoY.

Annual Net Profit Veracyte Inc Dec-2025 Annual Net Profit is $66 Million which is growth of 174.9% YoY.

Veracyte Inc - Balance Sheet

Veracyte Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Veracyte Inc Dec-2025 Total Shareholders Fund is $1,310 Million which is growth of 11.4% YoY.

Total Assets Veracyte Inc Dec-2025 Total Assets is $1,406 Million which is growth of 8.2% YoY.

Veracyte Inc - Ratios

Veracyte Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Veracyte Inc Book Value Per Share is $16 which is growth of 9.2% YoY.

ROE Veracyte Inc ROE is 0% which is growth of 0% YoY.

Veracyte Inc - Cash Flow

Veracyte Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Veracyte Inc Dec-2025 Cash From Operating Activity is $136 Million which is growth of 81.5% YoY.

Net Cash Flow Veracyte Inc Dec-2025 Net Cash Flow is $123 Million which is growth of 417.9% YoY.